Authors


Peter Latham

Latest:

Costing Issues in the Production of Biopharmaceuticals

Operational planning and early cost analyses are key to generating optimal, robust, and economical commercial processes.


Ron Lee

Latest:

Ice Fog as a Means to Induce Uniform Ice Nucleation During Lyophilization (Peer Reviewed)

The authors describe a novel means to control ice nucleation using a sterile cryogenic ice fog.


Lars Gøran Wistrand

Latest:

A Method for Removal of Endotoxin from Pharmaceutical Formulation

The authors describe a simple method to remove endotoxins from highly viscous formulations.


Ernest Jenness

Latest:

Single-Use Technology for Syringe Filling

A novel approach to sterile drug product manufacturing uses a single-use assembly in a multi-product final filling suite with isolator technology.



Christopher Milne

Latest:

The Case for Pediatric Exclusivity

Reauthorization of pediatric exclusivity provisions looms in 2012 and debates begin anew.



Robert B. Burlingame

Latest:

A Protocol for Trademark Protection

The Madrid Protocol offers companies another option for trademark registration on a global scale.


Vijesh Kumar

Latest:

Mechanistic Modeling of Preparative Ion-Exchange Chromatography

Chromatography modeling can enhance bioprocessing efficiencies.




Paul Nelles

Latest:

Strategic Outsourcing in Clinical Development

Partnering with CDMOs can help bridge the innovation gap.


Arie Geursen

Latest:

HIV Drugs Produced from Goats Show Promise

Molecular mimicry is a common, but undesirable, property of disease proteins. Sequence similarities between cancer proteins and self-proteins allow tumor cells to hide, thereby avoiding attack from the immune system. HIV uses the same evasive tactic.



James E. Seely, PhD

Latest:

Scaling Down of Biopharmaceutical Unit Operations — Part 2: Chromatography and Filtration

Creation and qualification of scale-down models is essential for performing several critical activities that support process validation and commercial manufacturing. This combined article is the fifth in the "Elements of Biopharmaceutical Production" series. Part 1 (March 2005) covered fermentation. In this segment, we present some guidelines and examples for scale-down of common downstream unit operations used in biotech processes - chromatography and filtration.


Sarfaraz K. Niazi

Latest:

Emerging Bioprocessing Methods

New technology is designed to improve production efficiency by taking advantage of the properties of single-use bags.


Bipul Pandey

Latest:

Knowledge Management Implementation

The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.


Pratik Jaluria

Latest:

Bucking the Trend

A perspective on why platform processes are not and should not define the future of bioprocess development efforts. This article is part of a special section on biopharmaceutical trends.


Nozer M. Mehta

Latest:

Oral Delivery and Recombinant Production of Peptide Hormones, Part II: Recombinant Production of Therapeutic Peptides

This technology includes an efficient and scalable in vitro enzymatic amidation step for peptide hormones.


Chet Meyers

Latest:

Reduce Analytical Testing and Costs Without Compromising Compliance

Unnecessary analytical testing can lead to unnecessary costs.


Nikhil Shaligram

Latest:

Process Development and Spiking Studies for Virus Filtration of r-hFSH

This study on a recombinant human follicle stimulating hormone demonstrates the use of virus filters to reduce the risk of contamination.



Ian Uydess

Latest:

Operational Excellence: More Than Just Process Improvement

By embracing efficiency and quality, biopharmaceutical organizations can work better and achieve better work.


Sibyl Shalo

Latest:

Oiling the Engines of Invention

Big Pharma execs bring to biotech the knowledge of what it takes to make something a commercial success-not getting to market, but to Phase I.



Roquette

Latest:

New Research Revealed on a Promising Functional Alternative to Surfactants within Biologic Formulations

New research shows KLEPTOSE® BIOPHARMA as a potential functional alternative to surfactants within biologic formulations, learn more from Roquette’s experts Peter Ferguson and Pen Tao. Live: Tuesday, Oct. 29, 2019 at 9am CDT | 10am EDT | 2pm GMT | 3pm CET On demand available after airing until Oct. 29, 2020 Register free


Luca Angiolini

Latest:

Efficient Prion Removal from Gonadotropin Solutions by Nanofiltration Membranes

Can a nanofiltration process be leveraged for removal of prions?


Bob Stewart

Latest:

A Look at INTERPHEX 2012

Collaboration can begin with a conversation.



© 2025 MJH Life Sciences

All rights reserved.